Mondaq All Regions - China: Food, Drugs, Healthcare, Life Sciences
Ropes & Gray LLP
On January 10, 2018, the China Food and Drug Administration announced the implementation of the Technical Guidelines Governing Acceptance of Medical Device Clinical Data from Foreign Studies.
CMS Cameron McKenna Nabarro Olswang LLP
The draft is open for public comments until 25 November 2017.
CMS Cameron McKenna Nabarro Olswang LLP
On 8 October 2017, the General Office of the State Council issued the Opinions on Deepening the Reform of the Evaluation and Approval System and Encouraging the Innovation of Drugs and Medical Devices.
CMS Cameron McKenna Nabarro Olswang LLP
Circular (2014) No.15 provides for the specific deadlines for different domestic medical devices manufacturing companies to gradually meet the Medical Devices Manufacturing Quality Management Standards
HFG Law Firm
O Parbleu! Thunderclap for the cheese gourmet! Recently China undertakes strengthened regulatory measures which have directly affected the long-term importation of certain types of European cheese...
CMS Cameron McKenna Nabarro Olswang LLP
The China Food and Drug Administration ("CFDA") promulgated a new circular (2017) No.68 related to the promotion of a drug market authorization holder regime ("MAH Regime") work on 21 August 2017...
Jincheng Tongda & Neal
China has been endeavoring to make comprehensive and fundamental regulatory reform of drug and medical device, in particular in the drug and medical device registration system.
Ropes & Gray LLP
The CFDA is soliciting public comments for these drafts until mid-January 2018.
MyLink Law Office
On 6 June 2016, China Food and Drug Administration ("CFDA") published Administrative Measures on Product Formula Registration of Infant Formula Milk Powder ("Measures") for purpose...
A&Z Law Firm
On September 24th, Ding Jianhua, director of the China Food and Drug Administration (CFDA) Supervision Department, stated at the 2017 Chinese Pharmaceutical Entrepreneurs, Scientists...
CMS Cameron McKenna Nabarro Olswang LLP
After receiving comments on the draft of the Decision of the State Administration of Food and Drug Administration on Adjusting the Relevant Issues Concerning the Registration and Administration...
A&Z Law Firm
Lately many restaurants in Shanghai have been broadcasting the work environment in the kitchen at their entrance (in real-time). What is that about?
Zhong Lun Law Firm
On October 23, 2017, the China Food and Drug Administration ("CFDA") released the revised Administrative Measures for Drug Registration ("Draft for Comment") for public comment.
CMS Cameron McKenna Nabarro Olswang LLP
After the State Council issued the Opinions on Deepening the Reform of Examination and Approval System and Encouraging Innovation of Drugs and Medical Devices ("Opinions") on 8 October 2017, ...
Ropes & Gray LLP
The opinions will create a level playground for R&D-focused drug and device companies, at home and abroad.
Ropes & Gray LLP
The China Food and Drug Administration (CFDA) has published its proposed amendment of the Medical Device Regulations (MDR), previously known as the State Council Order # 650, for public comments.
Ropes & Gray LLP
The China Food and Drug Administration (CFDA) published its proposed amendment of the Drug Administration Law (DAL) and the Drug Registration Rules (DRR) for public comments. This Alert summarizes the key changes.
Ropes & Gray LLP
In addition, the Final Policy attempts to strike a balance between the potentially conflicting interest of innovative and generic drug manufacturers.
McDermott Will & Emery
Hospitals in China differ greatly from those in the west with respect to their relationships with physicians and patients; but they also share some of the same legal challenges faced by western hospitals.
Ropes & Gray LLP
In China, medical devices are divided into three regulatory classes based on the identified risks associated with the devices.
Most Popular Recent Articles
Ropes & Gray LLP
The CFDA is soliciting public comments for these drafts until mid-January 2018.
Jincheng Tongda & Neal
China has been endeavoring to make comprehensive and fundamental regulatory reform of drug and medical device, in particular in the drug and medical device registration system.
A&Z Law Firm
On September 24th, Ding Jianhua, director of the China Food and Drug Administration (CFDA) Supervision Department, stated at the 2017 Chinese Pharmaceutical Entrepreneurs, Scientists...
A&Z Law Firm
Lately many restaurants in Shanghai have been broadcasting the work environment in the kitchen at their entrance (in real-time). What is that about?
Zhong Lun Law Firm
On October 23, 2017, the China Food and Drug Administration ("CFDA") released the revised Administrative Measures for Drug Registration ("Draft for Comment") for public comment.
CMS Cameron McKenna Nabarro Olswang LLP
The China Food and Drug Administration ("CFDA") promulgated a new circular (2017) No.68 related to the promotion of a drug market authorization holder regime ("MAH Regime") work on 21 August 2017...
CMS Cameron McKenna Nabarro Olswang LLP
After the State Council issued the Opinions on Deepening the Reform of Examination and Approval System and Encouraging Innovation of Drugs and Medical Devices ("Opinions") on 8 October 2017, ...
CMS Cameron McKenna Nabarro Olswang LLP
After receiving comments on the draft of the Decision of the State Administration of Food and Drug Administration on Adjusting the Relevant Issues Concerning the Registration and Administration...
MyLink Law Office
On 6 June 2016, China Food and Drug Administration ("CFDA") published Administrative Measures on Product Formula Registration of Infant Formula Milk Powder ("Measures") for purpose...
McDermott Will & Emery
The purchasing power of the Chinese middle class is reshaping the world's market for luxury brands, tourism, real estate, and private investments.
Ropes & Gray LLP
The opinions will create a level playground for R&D-focused drug and device companies, at home and abroad.
Han Kun Law Offices
Can foreign investors set up wholly-owned medical institutions in China? This is a question that clients constantly ask when entering the Chinese healthcare industry...
Article Search Using Filters
Related Topics
Popular Authors
Popular Contributors
Up-coming Events Search
Tools
Font Size:
Translation
Channels
Mondaq on Twitter